Answer
Gemfibrozil increases systemic exposure to montelukast 4.4-fold; no routine montelukast dose adjustment is required, but physicians should be aware of potentially increased adverse reactions.
Sources for this answer
- Singulair Paediatric 5 mg Chewable TabletsOrganon Pharma (UK) Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 19Document updated
Sources checked